Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

1.2K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.2K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

2.5K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.5K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

975
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
975
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

570
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
570
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

580
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
580

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multiple forms of protein-protein and DNA binding are exhibited by BrxC from the BREX phage restriction system.

Nucleic acids research·2026
Same author

Diagnostic Yield and Safety of Pulmonologist-Performed Ultrasound-Guided Transthoracic Core Biopsy: A Seven-Year Cohort Study.

Diagnostics (Basel, Switzerland)·2026
Same author

Therapy-Induced Cellular Senescence in Non-Hodgkin Lymphomas, with Emphasis on Aggressive B-Cell Subtypes: Molecular Mechanisms and Emerging Drug Targets.

Current cancer drug targets·2026
Same author

The Potential and Challenges of Focused Ultrasound-Mediated Therapies in the Management of Liver and Biliary Tract Cancers.

Cancers·2026
Same author

Integrating Flow Cytometry in the Diagnostic Work of HIV-Associated Hodgkin's Lymphomas.

Journal of cellular and molecular medicine·2026
Same author

Pediatric Autoimmune Sclerosing Cholangitis: Diagnostic and Therapeutic Challenges.

Pediatric reports·2026
Same journal

circFOXP1 Promotes Pancreatic Ductal Adenocarcinoma Progression Through Regulating EREG/MAPK/ERK Axis.

Journal of cellular and molecular medicine·2026
Same journal

Circular RNA circ_0003423 Promotes Osteoarthritis Progression by Sponging miR-330-5p to Upregulate TWIST1-Mediated Chondrocyte Inflammation and Extracellular Matrix Degradation.

Journal of cellular and molecular medicine·2026
Same journal

Multi-Omics Landscape of Paraspinal Muscles in Spinal Muscular Atrophy With Scoliosis.

Journal of cellular and molecular medicine·2026
Same journal

Overexpression of Circular RNA circTTN Promotes Ferroptosis in Sepsis-Induced Cardiomyopathy.

Journal of cellular and molecular medicine·2026
Same journal

PLOD1 Drives Head and Neck Squamous Cell Carcinoma Progression Through P4HA2-Mediated Activation of the FAK/PI3K/AKT/mTOR Axis.

Journal of cellular and molecular medicine·2026
Same journal

Valsartan Reduces Myocardial Ischemia-Reperfusion Injury by Inhibiting Ferritinophagy-Mediated Ferroptosis.

Journal of cellular and molecular medicine·2026
See all related articles

Related Experiment Video

Updated: Feb 11, 2026

Genome-wide Snapshot of Chromatin Regulators and States in Xenopus Embryos by ChIP-Seq
10:23

Genome-wide Snapshot of Chromatin Regulators and States in Xenopus Embryos by ChIP-Seq

Published on: February 26, 2015

12.9K

Snapshot Look at Castleman Disease.

Ciprian Jitaru1,2,3, Natalia Zlampa1,2, Delia Dima3

  • 1Department of Personalized Medicine and Rare Diseases, Medfuture Institute for Biomedical Research, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.

Journal of Cellular and Molecular Medicine
|February 10, 2026
PubMed
Summary
This summary is machine-generated.

Castleman disease (CD) is a rare lymphoproliferative disorder with unicentric (UCD) and multicentric (MCD) forms. Research highlights IL-6, HHV8, and immune signaling roles, emphasizing the need for better diagnostics and targeted therapies for improved patient outcomes.

Keywords:
Castleman diseaseneed‐to‐know information for the cliniciansnapshot look

More Related Videos

Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model
06:19

Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model

Published on: October 20, 2023

2.9K
Quantitative Analysis of Chromatin Proteomes in Disease
08:11

Quantitative Analysis of Chromatin Proteomes in Disease

Published on: December 28, 2012

13.7K

Related Experiment Videos

Last Updated: Feb 11, 2026

Genome-wide Snapshot of Chromatin Regulators and States in Xenopus Embryos by ChIP-Seq
10:23

Genome-wide Snapshot of Chromatin Regulators and States in Xenopus Embryos by ChIP-Seq

Published on: February 26, 2015

12.9K
Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model
06:19

Author Spotlight: A Personalized Approach Towards Investigating Alzheimer's Disease Using an In Vitro Blood-Brain Barrier Model

Published on: October 20, 2023

2.9K
Quantitative Analysis of Chromatin Proteomes in Disease
08:11

Quantitative Analysis of Chromatin Proteomes in Disease

Published on: December 28, 2012

13.7K

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Castleman disease (CD) is a rare, heterogeneous lymphoproliferative disorder.
  • Classified into unicentric CD (UCD) and multicentric CD (MCD), with MCD further subtyped (HHV8-associated, POEMS-associated, idiopathic).

Purpose of the Study:

  • To review current knowledge on Castleman disease epidemiology, presentation, pathology, pathogenesis, and diagnosis.
  • To explore recent advances in molecular biology and therapeutic strategies for CD.

Main Methods:

  • Literature review of epidemiology, clinical presentation, histopathology, pathogenesis, and diagnostics.
  • Exploration of molecular biology, including IL-6, HHV8, and immune signaling.
  • Summary of current therapeutic strategies for different CD subtypes.

Main Results:

  • CD involves abnormal lymphoid tissue proliferation with distinct subtypes.
  • Key molecular factors include IL-6, HHV8, and aberrant immune signaling.
  • Treatment varies from surgery for UCD to immunotherapy and chemotherapy for MCD.

Conclusions:

  • Castleman disease remains underdiagnosed, particularly idiopathic forms.
  • Further research into molecular mechanisms and targeted treatments is crucial.
  • Establishing evidence-based guidelines is essential for improving patient care.